Latest News

April 25, 2014
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
March 12, 2014
It doesn’t always make sense to do a heart scan to measure how much plaque has built up in a patient’s coronary arteries before prescribing statins, UCSF research shows.
March 11, 2014
Laura van ‘t Veer, PhD, was honored this week as one of the top female scientific innovators in Europe, winning one of the 2014 European Union Prizes for Women Innovators.
March 07, 2014
In its fourth year of supporting early translational research, the Catalyst Awards program wrapped up its Fall 2013 cycle with nine finalists presenting their research ideas to industry and academic experts in research, product development and commercialization.
January 21, 2014
Clay Johnston, MD, PhD, a physician-scientist and director of the Clinical and Translational Science Institute, is leaving UCSF at the end of February to become the inaugural dean of the Dell School of Medicine at The University of Texas at Austin.
October 14, 2013
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
October 14, 2013
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
October 14, 2013
A team of UCSF researchers developing cell-based therapies for acute respiratory distress syndrome benefited from advisors who helped identify gaps in their development plan.
October 14, 2013
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
September 27, 2013
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.

Pages